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During the 2019-2020 winter season, the Northern 
Hemisphere was called to face the experience of a 
simultaneous epidemic of coronavirus disease 2019 
(COVID-19) and seasonal influenza [1]. Recent stud-
ies have documented in SARS-CoV-2 positive pa-
tients, early in the COVID-19 pandemic, a co-infec-
tion with other respiratory pathogens, including influ-
enza  [2-4]. The potential occurrence of co-infection 
underscored the need for simultaneous detection and 
evaluation in order to improve the differential diagno-
sis in patients with acute respiratory syndromes [5].
In Italy, the SARS-CoV-2 epidemic started around 
mid-February 2020 in Lombardy (Northern Italy) and, 
since then, new cases of infection have been reported 
in a number of other northern Italian regions, such 
as Veneto, Emilia-Romagna, Piedmont, Liguria, and 
Marche. More in depth, following the detection of two 
imported cases involving Chinese travelers on Janu-
ary  31st, 2020  [6,  7], the first autochthonous patient 
affected by COVID-19 (“patient zero”) was identified 
on February 19, 2020 in a 38-year-old Caucasian male 
from Codogno town. On February 21, 2020 the first 
cluster of 16 Italian cases was reported in Lombardy, 
followed by a number of new notified cases exponen-
tially growing, until when, on February 22nd, 2020, 
public health authorities established a “red zone” en-
compassing 11 municipalities to contain the epidem-
ic. Thereafter, in a short time, the epidemic spread to 
the neighboring regions located in the northern and 
central part of the country [8, 9], with a substantially 
lower impact on the rest of the country.
In Sicily, the largest and southernmost region of Italy, 
as well as the fourth most populated one, the first con-
firmed case of SARS-CoV-2 infection was a 65-year-
old woman from Bergamo (Lombardy), who was 
already on holiday in Palermo city a couple of days 
before the detection of “patient zero” in Codogno. 
This subject showed symptoms possibly referring to 
COVID-19 on February 23rd, 2020 and tested positive 
at SARS-CoV-2 molecular investigation on February 
24th, 2020, followed the day after by two of the other 
twenty-nine fellow companions.
Nevertheless, the first Sicilian autochthonous SARS-
CoV-2 cases occurred early in March, most of them in 
close association with individuals who had travelled 
to or returned back from Lombardy in the previous 
week. Early in the course of the outbreak, severe con-
tainment measures were adopted by the Italian gov-
ernment throughout the entire country, which resulted 
in lockdown restrictions since March 9, 2020. These 
measures determined different local patterns of viral 
spread and Sicily took a clear advantage of this provi-
sion, experiencing low incidence of COVID-19 in the 
first semester of pandemic [10].
Of interest, chronologically-speaking, the early phase 
of SARS-CoV-2 epidemic partially overlapped the 
latter part of the seasonal influenza outbreak, which is 
annually explored during the winter through a nation-
wide sentinel surveillance network (InfluNet) [11], to 
which the Sicilian Reference Laboratory belongs.
However, to date, no official laboratory data have 
been made available in order to get a shot of the real 
beginning of the spread of SARS-CoV-2 in Sicily. 
Therefore, to gain further understanding on the local 
transmission of SARS-CoV-2, respiratory specimens 
routinely collected in the framework of the 2019-2020 
seasonal influenza virus surveillance were retrospec-
tively re-evaluated by molecular testing for SARS-
CoV-2. To this end, 2,330 samples collected from pa-
tients presenting with Influenza-like illness, between 
October 2019 and February 2020, were analyzed by 
reverse transcriptase real-time PCR, targeting differ-
ent segments of the N gene of the SARS-CoV-2 ge-
nome  [12]. Briefly, collected data showed that none 
of these samples tested positive for SARS-CoV-2, 
documenting no co-infection with influenza virus and 
confirming at the same time that in Sicily there has 
not been any circulation of the pandemic virus prior 
to the first documented cases.
As stated above, from an epidemiological point of 
view, in Italy SARS-CoV-2 spread in an asynchronous 
way, showing different local patterns either in terms of 
incidence rates or affected geographic areas. Our data 
confirmed that SARS-CoV-2 appeared in Sicily at a 
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later stage of the outbreak documented in Italy and, ac-
cording to severe containment measures adopted by the 
Italian government, slowly spread with low incidence.
Nevertheless, despite the epidemiology of COVID-19 
and of seasonal influenza is different, symptoms re-
lated to the two mentioned diseases overlap, and their 
confluence has been expected to result in higher mor-
bidity and mortality rates, with additional stress to the 
entire public health system [13, 14]. Therefore, a wide-
spread use of influenza vaccination has been promoted 
during the current season 2020-2021 in combination 
of containment measures (i.e. correct use of personnel 
protection equipment, hand washing, social distancing, 
etc.). At the midterm of the current surveillance season, 
we were able to demonstrate also in Sicily the dramatic 
global decline in influenza virus circulation, as clearly 
documented through the national virological surveil-
lance networks in Italy [15] and elsewhere [16-18].
Lastly, the body of the previous evidences highlights 
the importance of molecular diagnostic testing for 
SARS-CoV-2 both to distinguish between influenza 
and COVID-19 in patients with acute respiratory ill-
ness, and to provide continuous surveillance and 
timely tracing to define and rapidly implement effec-
tive containment measures.
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